Taiho Pharmaceutical Co., Ltd.
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:focusArea |
gptkb:allergy
immunology oncology |
| gptkbp:founded |
1963
|
| gptkbp:headquarters_location |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Taiho Pharmaceutical Co., Ltd.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
gptkb:Masayuki_Kobayashi
|
| gptkbp:notableProduct |
gptkb:Abraxane
gptkb:Teysuno gptkb:Lonsurf |
| gptkbp:numberOfEmployees |
over 1,500
|
| gptkbp:parentCompany |
gptkb:Otsuka_Holdings_Co.,_Ltd.
|
| gptkbp:products |
oncology drugs
immunology drugs allergy drugs |
| gptkbp:stockExchange |
not publicly traded
|
| gptkbp:subsidiary |
gptkb:Otsuka_Holdings_Co.,_Ltd.
|
| gptkbp:website |
https://www.taiho.co.jp/en/
|
| gptkbp:bfsParent |
gptkb:Otsuka
|
| gptkbp:bfsLayer |
6
|